Foresight 3 VCT PLC Foresight 3 Vct Plc : Interim Management Statement


 
TIDMFTD 
 
   Foresight 3 VCT plc 
 
   Interim Management Statement for the Quarter Ended 30 June 2014 
 
   Foresight 3 VCT plc presents its Interim Management Statement for the 
quarter ended 30 June 2014.  This constitutes the company's first 
Interim Management Statement for the financial year ending 31 March 
2015, as required by the UK Listing Authority's Disclosure and 
Transparency Rule 4.3. 
 
   The unaudited net asset value (NAV) per ordinary share as at 30 June 
2014 was 73.4p (31 March 2014: 74.2p). 
 
 
 
   At 30 June 2014 there were 51,226,401 Ordinary Shares in issue. There 
were no shares issued or repurchased during the quarter. 
 
   The net assets at 30 June 2014 comprised the following: 
 
 
 
 
                                                      GBP'000  % of Net Assets 
Unquoted Investments at fair value as determined by 
 the Directors                                         35,376             94.1 
Quoted investments at bid price                           208              0.6 
Total venture capital investments                      35,584             94.7 
Cash & liquid investments                                 137              0.4 
Other net current assets                                1,858              4.9 
Net Assets                                             37,579            100.0 
 
 
   Quoted investments are stated at bid price as at 30 June 2014.  Unquoted 
investments are stated at fair value as at 30 June 2014 as determined by 
the Directors. 
 
   During the three months ended 30 June 2014 the following investment 
addition and disposals took place: 
 
   Investment addition: 
 
 
 
 
Name of                                                                  Type of    Amount Invested 
Company      Business Activity                                           addition       GBP'000 
             Molecular diagnostics business expertise in the important 
              area of enzyme stabilisation, effectively hi-tech          Growth 
Biofortuna    freeze drying.                                              capital                51 
 
 
   Investment disposals: 
 
 
 
 
Name of                                                              Type of         Amount Invested  Proceeds 
Company     Business Activity                                        disposal            GBP'000       GBP'000 
Meridian    Creating pre-operative plans from digital x-ray images 
 Technique   for orthopaedic surgeons                                Loan repayment              151       151 
Evance 
 Wind 
 Turbines                                                            Payment from 
 Limited    UK based manufacturer of small wind turbines              administrator              142       142 
Xention 
 Pharma 
 Limited    Ion channel drug discovery company                       Trade sale                  712        10 
 
   For further information please contact: 
 
   Gary Fraser, Foresight Group:                            020 3667 8100 
 
   This announcement is distributed by NASDAQ OMX Corporate Solutions on 
behalf of NASDAQ OMX Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Foresight 3 VCT PLC via Globenewswire 
 
   HUG#1857215 
 
 
  http://www.foresightgroup.eu/

Foresight 3 Vct (LSE:FTD)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024